| Year |
Citation |
Score |
| 2024 |
Neeb A, Figueiredo I, Bogdan D, Cato L, Stober J, Jiménez-Vacas JM, Gourain V, Lee II, Seeger R, Muhle-Goll C, Gurel B, Welti J, Nava Rodrigues D, Rekowski J, Qiu X, et al. Thio-2 inhibits key signaling pathways required for the development and progression of castration resistant prostate cancer. Molecular Cancer Therapeutics. PMID 38412481 DOI: 10.1158/1535-7163.MCT-23-0354 |
0.685 |
|
| 2024 |
Poluben L, Nouri M, Liang J, Varkaris A, Ersoy-Fazlioglu B, Voznesensky O, Lee II, Qiu X, Cato L, Seo JH, Freedman ML, Sowalsky AG, Lack NA, Corey E, Nelson PS, et al. Increased chromatin accessibility drives transition to androgen receptor splice variant dependence in castration-resistant prostate cancer. Biorxiv : the Preprint Server For Biology. PMID 38260576 DOI: 10.1101/2024.01.10.575110 |
0.683 |
|
| 2023 |
Pan M, Solozobova V, Kuznik NC, Jung N, Gräßle S, Gourain V, Heneka YM, Cramer von Clausbruch CA, Fuhr O, Munuganti RSN, Maddalo D, Blattner C, Neeb A, Sharp A, Cato L, et al. Identification of an Imidazopyridine-based Compound as an Oral Selective Estrogen Receptor Degrader for Breast Cancer Therapy. Cancer Research Communications. 3: 1378-1396. PMID 37520743 DOI: 10.1158/2767-9764.CRC-23-0111 |
0.682 |
|
| 2022 |
Cato L, Shomali M. AR Structural Variants and Prostate Cancer. Advances in Experimental Medicine and Biology. 1390: 195-211. PMID 36107320 DOI: 10.1007/978-3-031-11836-4_11 |
0.658 |
|
| 2022 |
Kuznik NC, Solozobova V, Lee II, Jung N, Yang L, Nienhaus K, Ntim EA, Rottenberg JT, Muhle-Goll C, Kumar AR, Peravali R, Gräßle S, Gourain V, Deville C, Cato L, et al. A chemical probe for BAG1 targets androgen receptor-positive prostate cancer through oxidative stress signaling pathway. Iscience. 25: 104175. PMID 35479411 DOI: 10.1016/j.isci.2022.104175 |
0.72 |
|
| 2021 |
Liang J, Wang L, Poluben L, Nouri M, Arai S, Xie L, Voznesensky OS, Cato L, Yuan X, Russo JW, Long HW, Brown M, Chen S, Balk SP. Androgen receptor splice variant 7 functions independently of the full length receptor in prostate cancer cells. Cancer Letters. PMID 34256096 DOI: 10.1016/j.canlet.2021.07.013 |
0.709 |
|
| 2019 |
Cato L, de Tribolet-Hardy J, Lee I, Rottenberg JT, Coleman I, Melchers D, Houtman R, Xiao T, Li W, Uo T, Sun S, Kuznik NC, Göppert B, Ozgun F, van Royen ME, et al. ARv7 Represses Tumor-Suppressor Genes in Castration-Resistant Prostate Cancer. Cancer Cell. PMID 30773341 DOI: 10.1016/J.Ccell.2019.01.008 |
0.78 |
|
| 2017 |
Luo J, Attard G, Balk SP, Bevan C, Burnstein K, Cato L, Cherkasov A, De Bono JS, Dong Y, Gao AC, Gleave M, Heemers H, Kanayama M, Kittler R, Lang JM, et al. Role of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants Meeting. European Urology. PMID 29258679 DOI: 10.1016/J.Eururo.2017.11.038 |
0.682 |
|
| 2017 |
Cato L, Neeb A, Sharp A, Buzón V, Ficarro SB, Yang L, Muhle-Goll C, Kuznik NC, Riisnaes R, Nava Rodrigues D, Armant O, Gourain V, Adelmant G, Ntim EA, Westerling T, et al. Development of Bag-1L as a therapeutic target in androgen receptor-dependent prostate cancer. Elife. 6. PMID 28826504 DOI: 10.7554/Elife.27159 |
0.705 |
|
| 2017 |
Fei T, Chen Y, Xiao T, Li W, Cato L, Zhang P, Cotter MB, Bowden M, Lis RT, Zhao SG, Wu Q, Feng FY, Loda M, He HH, Liu XS, et al. Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. Proceedings of the National Academy of Sciences of the United States of America. PMID 28611215 DOI: 10.1073/Pnas.1617467114 |
0.635 |
|
| 2017 |
Tavera-Mendoza LE, Westerling T, Libby E, Marusyk A, Cato L, Cassani R, Cameron LA, Ficarro SB, Marto JA, Klawitter J, Brown M. Vitamin D receptor regulates autophagy in the normal mammary gland and in luminal breast cancer cells. Proceedings of the National Academy of Sciences of the United States of America. PMID 28242709 DOI: 10.1073/Pnas.1615015114 |
0.532 |
|
| 2017 |
Cato L, Neeb A, Sharp A, Buzón V, Ficarro SB, Yang L, Muhle-Goll C, Kuznik NC, Riisnaes R, Rodrigues DN, Armant O, Gourain V, Adelmant G, Ntim EA, Westerling T, et al. Author response: Development of Bag-1L as a therapeutic target in androgen receptor-dependent prostate cancer Elife. DOI: 10.7554/Elife.27159.041 |
0.723 |
|
| 2016 |
Groner AC, Cato L, de Tribolet-Hardy J, Bernasocchi T, Janouskova H, Melchers D, Houtman R, Cato AC, Tschopp P, Gu L, Corsinotti A, Zhong Q, Fankhauser C, Fritz C, Poyet C, et al. TRIM24 Is an Oncogenic Transcriptional Activator in Prostate Cancer. Cancer Cell. PMID 27238081 DOI: 10.1016/J.Ccell.2016.04.012 |
0.786 |
|
| 2016 |
Cato L, Neeb A, Sharp A, Ficarro S, Buzon V, Salvatella X, Marto JA, Bono JSd, Cato AC, Brown M. Abstract 864: Androgen receptor stability in prostate cancer is regulated by the cochaperone Bag-1L Endocrinology. 76: 864-864. DOI: 10.1158/1538-7445.Am2016-864 |
0.73 |
|
| 2016 |
Groner AC, Cato L, Tribolet-Hardy Jd, Bernasocchi T, Zhong Q, Fankhauser C, Fritz C, Poyet C, Wagner U, Garraway LA, Wild PJ, Theurillat J, Brown M. Abstract 1806: TRIM24 is an oncogenic transcriptional activator in prostate cancer Cancer Research. 76: 1806-1806. DOI: 10.1158/1538-7445.Am2016-1806 |
0.794 |
|
| 2015 |
Cato L, Neeb A, Adelmant G, Ficarro S, Westerling T, Marto JA, Cato AC, Brown M. Abstract 4677: Control of androgen receptor function by the genomic action of the cochaperone Bag-1L Cancer Research. 75: 4677-4677. DOI: 10.1158/1538-7445.Am2015-4677 |
0.733 |
|
| 2014 |
Cato L, Neeb A, Brown M, Cato AC. Control of steroid receptor dynamics and function by genomic actions of the cochaperones p23 and Bag-1L. Nuclear Receptor Signaling. 12: e005. PMID 25422595 DOI: 10.1621/Nrs.12005 |
0.573 |
|
| 2014 |
Jehle K, Cato L, Neeb A, Muhle-Goll C, Jung N, Smith EW, Buzon V, Carbó LR, Estébanez-Perpiñá E, Schmitz K, Fruk L, Luy B, Chen Y, Cox MB, Bräse S, et al. Coregulator control of androgen receptor action by a novel nuclear receptor-binding motif. The Journal of Biological Chemistry. 289: 8839-51. PMID 24523409 DOI: 10.1074/Jbc.M113.534859 |
0.635 |
|
| 2013 |
Cato L, Jehle K, Neeb A, Cato AC, Brown M. Control of androgen receptor action by a novel nuclear receptor binding motif in Bag-1L Epigenetics & Chromatin. 6. DOI: 10.1186/1756-8935-6-S1-P13 |
0.684 |
|
| 2012 |
Xu K, Wu ZJ, Groner AC, He HH, Cai C, Lis RT, Wu X, Stack EC, Loda M, Liu T, Xu H, Cato L, Thornton JE, Gregory RI, Morrissey C, et al. EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent. Science (New York, N.Y.). 338: 1465-9. PMID 23239736 DOI: 10.1126/Science.1227604 |
0.781 |
|
| 2011 |
Cato L, Brown M. Abstract 260: Identification of the role of linker histone H1 in estrogen receptor binding and activity Cancer Research. 71: 260-260. DOI: 10.1158/1538-7445.Am2011-260 |
0.586 |
|
| Show low-probability matches. |